|
|
Evaluation Value Analysis of NIHSS Score Combined with Plasma Copeptin and D-dimer in Patients with Acute Ischemic Stroke |
Lu Kehong |
Emergency Department of Beicheng Hospital,Linyi Traditional Chinese Medicine Hospital,Linyi,Shandong,276000 China |
|
|
Abstract Objective To explore the value of National Institutes of Health Stroke Scale(NIHSS)score combined with plasma and peptidogysin(Copeptin)and D-dimer for disease progression in patients with acute ischemic stroke(AIS). Methods 90 AIS patients were selected for the study.According to the NIHSS score,they were mild into moderate group(15 points,n=67)and severe group(>15 points n=23),and 40 healthy patients included in the physical examination in the same period were healthy group.Comparing differences in NIHSS scores,plasma Copeptin and D-dimer levels,analyzed the correlation between Copeptin and D-dimer levels and disease progression in AIS patients,binary logistic analyzed the relationship between Copeptin and D-dimer levels and disease progression,and ROC analyzed the value of Copeptin and D-dimer on disease progression in AIS patients. Results NIHSS score and Copeptin and D-dimer levels in AIS and severe group were higher than healthy and mild to moderate groups(P<0.05);Copeptin,D-dimer levels were positively correlated with disease progression in AIS patients(P<0.05);Binary logistics regression analysis showed that,Copeptin And D-dimer levels were related factors affecting disease progression in AIS patients(P<0.05);ROC result display,The AUC of Copeptin and D-dimer evaluation for the disease progression in AIS patients were 0.933 and 0.969,respectively,The AUC for the combined diagnosis was 0.988,A sensitivity of 95.65%,The specificity ratio was 82.09%. Conclusion The plasma levels of Copeptin and D-dimer in AIS patients are high,which are correlated with admission NIHSS score,are the relevant influencing factors of disease progression,and have certain reference value in clinical diagnosis.
|
Received: 15 February 2025
|
|
|
|
|
[1] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性卒中诊治指南2023[J].中华神经科杂志,2024,57(6):523-559. [2] 贾莉子,李晓燕,杜宁.缺血性脑卒中病人定量脑电图参数与梗死面积、NIHSS评分的相关性[J].中西医结合心脑血管病杂志,2023,21(1):161-164. [3] 温伟,文力,安稳,等.和肽素联合肌钙蛋白Ⅰ评估老年急性心肌梗死患者预后的价值[J].中华老年医学杂志,2022,41(2):135-138. [4] 滕雨明,韩广淞,沙宇惠,等.血浆D-二聚体水平与急性缺血性脑卒中病因分型、严重程度及预后的相关性研究[J].中风与神经疾病杂志,2022,39(5):388-393. [5] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666-682. [6] 胡周全,江朋,唐勇,等.全身免疫炎症指数及美国国立卫生研究院卒中量表评分对急性缺血性脑卒中患者静脉溶栓后短期预后的评估效力分析[J].华西医学,2024,39(5):699-704. [7] 解霖霖,张萌,王琨,等.发病后24h NIHSS评分预测急性缺血性卒中患者血管内机械血栓切除术后转归[J].国际脑血管病杂志,2022,30(10):732-737. [8] 周丽坤,马金珠,张蕾,等.白细胞介素18、热休克蛋白65和和肽素与中青年缺血性脑卒中的相关性研究[J].心脑血管病防治,2021,21(5):465-468. [9] 梁国聪,陈军,林力峰,等.血清和肽素水平对急性缺血性脑卒中患者静脉溶栓后出血转化的预测价值[J].广西医科大学学报,2021,38(11):2163-2167. [10] 江朋,唐勇,丁鑫.血浆D-二聚体和血小板/淋巴细胞比值联合NIHSS评分对急性缺血性脑卒中患者短期预后的评估效力[J].四川医学,2023,44(12):1265-1270. [11] 邹辉,杜鑫.血清D-二聚体和间接胆红素水平在预测缺血性脑卒中溶栓后脑出血转化的临床价值[J].实用医院临床杂志,2022,19(6):130-133. |
[1] |
Li Zhiyun, Ning Qun, Zhang Peng, Chen Mei, Zhang Zhenhong, Wang Yubin. Effect of Ginkgo Diterpene Lactone Meglumine Injection Combined with Acupuncture on Limb Function Recovery and Serum Hcy and D-D in Patients with Hemiplegia after Stroke[J]. journal1, 2025, 45(1): 112-115. |
[2] |
Zhang Yingyun. Analysis of the Test Results and Clinical Significance of Four Indicators of D-dimer and Blood Coagulation in Early,Middle and Late Pregnancy of Pregnant Women[J]. journal1, 2024, 44(3): 17-19. |
[3] |
. [J]. journal1, 2024, 44(1): 127-129. |
[4] |
. [J]. journal1, 2023, 43(5): 59-60. |
[5] |
. [J]. journal1, 2023, 43(3): 65-66. |
[6] |
. [J]. journal1, 2023, 43(3): 67-69. |
|
|
|
|